Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	GLRA3 GLRA1 GLRA2	5.07e-06	6	128	3	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	GLRA3 GLRA1 GLRA2	5.07e-06	6	128	3	GO:0016934
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	GLRA3 GLRA1 GLRA2	1.41e-05	8	128	3	GO:0005237
GeneOntologyMolecularFunction	protein serine kinase activity	MAPKAPK2 RPS6KA3 MINK1 NEK9 MAP3K4 NEK4 PIK3CB TSSK3 MAP3K7 MAP4K2 MAP3K2	2.25e-05	363	128	11	GO:0106310
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH2 CCDC88B DNAH5 DNAH11	2.93e-05	28	128	4	GO:0051959
GeneOntologyMolecularFunction	glycine-gated chloride ion channel activity	GLRA3 GLRA2	4.08e-05	2	128	2	GO:0022852
GeneOntologyMolecularFunction	glycine binding	GLRA3 GLRA1 GLRA2	8.89e-05	14	128	3	GO:0016594
GeneOntologyMolecularFunction	kinase activity	MAPKAPK2 RPS6KA3 MINK1 MAGI3 TEK NEK9 MAP3K4 NEK4 PIK3CB DGKK TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	1.14e-04	764	128	15	GO:0016301
GeneOntologyMolecularFunction	protein kinase activity	MAPKAPK2 RPS6KA3 MINK1 TEK NEK9 MAP3K4 NEK4 PIK3CB TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	1.28e-04	600	128	13	GO:0004672
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	MAPKAPK2 RPS6KA3 MINK1 NEK9 MAP3K4 NEK4 PIK3CB TSSK3 MAP3K7 MAP4K2 MAP3K2	1.42e-04	446	128	11	GO:0004674
GeneOntologyMolecularFunction	excitatory extracellular ligand-gated monoatomic ion channel activity	GLRA3 GLRA1 GLRA2 SLC17A7	1.64e-04	43	128	4	GO:0005231
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	MAPKAPK2 RPS6KA3 MINK1 TEK NEK9 MAP3K4 NEK4 PIK3CB DGKK TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	1.85e-04	709	128	14	GO:0016773
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH2 DNAH5 DNAH11	1.96e-04	18	128	3	GO:0008569
GeneOntologyMolecularFunction	chloride channel activity	GLRA3 GLRA1 GLRA2 SLC17A7 MFSD8	2.30e-04	86	128	5	GO:0005254
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GLRA3 GLRA1 GLRA2 SLC17A7	2.95e-04	50	128	4	GO:0099095
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	MAPKAPK2 POLA1 RPS6KA3 MINK1 MAGI3 TEK NEK9 MAP3K4 NEK4 PIK3CB DGKK TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	3.32e-04	938	128	16	GO:0016772
GeneOntologyMolecularFunction	monoatomic anion channel activity	GLRA3 GLRA1 GLRA2 SLC17A7 MFSD8	5.30e-04	103	128	5	GO:0005253
GeneOntologyMolecularFunction	MAP kinase kinase kinase kinase activity	MAP3K7 MAP4K2	6.01e-04	6	128	2	GO:0008349
GeneOntologyMolecularFunction	MAP kinase kinase kinase activity	MAP3K4 MAP3K7 MAP3K2	6.72e-04	27	128	3	GO:0004709
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	GLRA3 GLRA1 GLRA2 SLC17A7 MFSD8	1.27e-03	125	128	5	GO:0015108
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	GLRA3 GLRA1 GLRA2 SLC17A7	1.52e-03	77	128	4	GO:0005230
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH2 DNAH5 DNAH11	1.70e-03	37	128	3	GO:0045505
GeneOntologyCellularComponent	chloride channel complex	GLRA3 GLRA1 GLRA2 SLC17A7 MFSD8	2.39e-05	57	126	5	GO:0034707
GeneOntologyCellularComponent	glycinergic synapse	GLRA3 GLRA1 GLRA2	2.26e-04	20	126	3	GO:0098690
Domain	Glycine_rcpt_A	GLRA3 GLRA1 GLRA2	1.25e-06	4	128	3	IPR008127
Domain	DHC_N1	DNAH2 DNAH5 DNAH11	1.72e-05	8	128	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH2 DNAH5 DNAH11	1.72e-05	8	128	3	IPR013594
Domain	S_TKc	MAPKAPK2 RPS6KA3 MINK1 TEK NEK9 MAP3K4 NEK4 TSSK3 MAP3K7 MAP4K2 MAP3K2	3.72e-05	359	128	11	SM00220
Domain	Protein_kinase_ATP_BS	MAPKAPK2 RPS6KA3 MINK1 TEK MAP3K4 NEK4 TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	6.07e-05	379	128	11	IPR017441
Domain	PROTEIN_KINASE_ATP	MAPKAPK2 RPS6KA3 MINK1 TEK NEK9 MAP3K4 NEK4 TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	7.59e-05	459	128	12	PS00107
Domain	Kinase-like_dom	MAPKAPK2 RPS6KA3 MINK1 TEK NEK9 MAP3K4 NEK4 PIK3CB TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	9.03e-05	542	128	13	IPR011009
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	IPR024317
Domain	Dynein_HC_stalk	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	IPR013602
Domain	DHC_N2	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	IPR011704
Domain	MT	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	PF12777
Domain	AAA_8	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	PF12780
Domain	AAA_5	DNAH2 DNAH5 DNAH11	1.08e-04	14	128	3	PF07728
Domain	DHC_fam	DNAH2 DNAH5 DNAH11	1.35e-04	15	128	3	IPR026983
Domain	Dynein_heavy	DNAH2 DNAH5 DNAH11	1.35e-04	15	128	3	PF03028
Domain	Dynein_heavy_dom	DNAH2 DNAH5 DNAH11	1.35e-04	15	128	3	IPR004273
Domain	Prot_kinase_dom	MAPKAPK2 RPS6KA3 MINK1 TEK NEK9 MAP3K4 NEK4 TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	1.38e-04	489	128	12	IPR000719
Domain	PROTEIN_KINASE_DOM	MAPKAPK2 RPS6KA3 MINK1 TEK NEK9 MAP3K4 NEK4 TSSK3 MERTK MAP3K7 MAP4K2 MAP3K2	1.49e-04	493	128	12	PS50011
Domain	Ser/Thr_kinase_AS	MAPKAPK2 RPS6KA3 MINK1 NEK9 MAP3K4 NEK4 TSSK3 MAP3K7 MAP4K2 MAP3K2	1.77e-04	357	128	10	IPR008271
Domain	PROTEIN_KINASE_ST	MAPKAPK2 RPS6KA3 MINK1 NEK9 MAP3K4 NEK4 TSSK3 MAP3K7 MAP4K2 MAP3K2	1.98e-04	362	128	10	PS00108
Domain	Pkinase	MAPKAPK2 RPS6KA3 MINK1 NEK9 MAP3K4 NEK4 TSSK3 MAP3K7 MAP4K2 MAP3K2	2.98e-04	381	128	10	PF00069
Domain	GABAA/Glycine_rcpt	GLRA3 GLRA1 GLRA2	5.04e-04	23	128	3	IPR006028
Domain	Gal_Oxase/kelch_b-propeller	RAG2 KLHL29 FBXO42 KLHL26	7.16e-04	59	128	4	IPR011043
Domain	Kelch_1	KLHL29 FBXO42 KLHL33 KLHL26	1.36e-03	70	128	4	PF01344
Domain	Kelch_1	KLHL29 FBXO42 KLHL33 KLHL26	1.36e-03	70	128	4	IPR006652
Domain	IG_FLMN	FLNB FLNC	2.02e-03	10	128	2	SM00557
Domain	Filamin	FLNB FLNC	2.46e-03	11	128	2	PF00630
Domain	FILAMIN_REPEAT	FLNB FLNC	2.46e-03	11	128	2	PS50194
Domain	Filamin/ABP280_rpt	FLNB FLNC	2.46e-03	11	128	2	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNB FLNC	2.46e-03	11	128	2	IPR017868
Domain	BTB-kelch_protein	KLHL29 KLHL33 KLHL26	3.18e-03	43	128	3	IPR017096
Domain	Neurotransmitter_ion_chnl_CS	GLRA3 GLRA1 GLRA2	3.62e-03	45	128	3	IPR018000
Domain	Neur_chan_memb	GLRA3 GLRA1 GLRA2	3.85e-03	46	128	3	PF02932
Domain	CNH	MINK1 MAP4K2	4.02e-03	14	128	2	SM00036
Domain	Neurotrans-gated_channel_TM	GLRA3 GLRA1 GLRA2	4.09e-03	47	128	3	IPR006029
Domain	-	GLRA3 GLRA1 GLRA2	4.09e-03	47	128	3	2.70.170.10
Domain	Neur_chan_LBD	GLRA3 GLRA1 GLRA2	4.09e-03	47	128	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GLRA3 GLRA1 GLRA2	4.09e-03	47	128	3	PS00236
Domain	Neur_channel	GLRA3 GLRA1 GLRA2	4.09e-03	47	128	3	IPR006201
Domain	Neur_chan_lig-bd	GLRA3 GLRA1 GLRA2	4.09e-03	47	128	3	IPR006202
Domain	-	RAG2 FBXO42 KLHL33	4.34e-03	48	128	3	2.120.10.80
Domain	CNH	MINK1 MAP4K2	4.62e-03	15	128	2	PF00780
Domain	CNH	MINK1 MAP4K2	4.62e-03	15	128	2	PS50219
Domain	CNH_dom	MINK1 MAP4K2	4.62e-03	15	128	2	IPR001180
Domain	Guanylate_kinase_CS	MAGI3 MAGI2	5.25e-03	16	128	2	IPR020590
Domain	Kelch-typ_b-propeller	RAG2 FBXO42 KLHL33	6.36e-03	55	128	3	IPR015915
Pathway	BIOCARTA_MAPK_PATHWAY	MAPKAPK2 RPS6KA3 MAP3K4 MAP3K7 MAP4K2 MAP3K2	1.12e-05	76	94	6	MM1433
Pathway	WP_INSULIN_SIGNALING	CYTH3 RPS6KA3 MINK1 MAP3K4 PIK3CB MAP3K7 MAP4K2 MAP3K2	1.13e-05	160	94	8	MM15956
Pathway	WP_INSULIN_SIGNALING	CYTH3 RPS6KA3 MINK1 MAP3K4 PIK3CB MAP3K7 MAP4K2 MAP3K2	1.13e-05	160	94	8	M39482
Pathway	BIOCARTA_MAPK_PATHWAY	MAPKAPK2 RPS6KA3 MAP3K4 MAP3K7 MAP4K2 MAP3K2	1.62e-05	81	94	6	M13863
Pathway	WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY	RPS6KA3 MINK1 MAP3K4 PIK3CB MAP3K7 MAP4K2 MAP3K2	2.80e-05	132	94	7	M39338
Pathway	WP_MAPK_SIGNALING	FLNB FLNC MAPKAPK2 RPS6KA3 MAP3K4 MAP3K7 MAP4K2 MAP3K2	2.35e-04	246	94	8	M39597
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PITPNM2 FLNB MAOA RHBDF2 MAPKAPK2 ABHD2 MINK1 MAGI3 PLD3 LIN52 NEK9 KIAA1671 CEP170 KLHL29 SCARB1 TTLL11 FBXO42 SMARCA2 TATDN1 CNOT1 PCNT KLHL26	3.01e-08	1489	129	22	28611215
Pubmed	A human MAP kinase interactome.	CASP8AP2 FLNC SUPT20H EXPH5 NEB CCDC88B MAP3K4 LENG8 CEP250 NKTR MPHOSPH9 MAP3K7 MAP3K2	3.57e-08	486	129	13	20936779
Pubmed	Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice.	GLRA3 GLRA1 GLRA2	4.99e-08	3	129	3	17920294
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRA3 GLRA1 GLRA2	1.99e-07	4	129	3	9051263
Pubmed	Glycinergic input of widefield, displaced amacrine cells of the mouse retina.	GLRA3 GLRA1 GLRA2	1.99e-07	4	129	3	19528249
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRA3 GLRA1 GLRA2	1.99e-07	4	129	3	21486797
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	VAPA FLNB FLNC ARID4A NBEAL1 SPCS2 CHORDC1 CEP170 ARHGAP1 AHNAK SCARB1 CIAPIN1 EIF3G	2.15e-07	568	129	13	37774976
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	SUPT20H NBEAL1 MAPKAPK2 POLA1 PLD3 CXXC1 P4HB SCARB1 NKTR EIF3G FTO PLEKHH2 PRRC2B DNAH11	3.02e-07	689	129	14	36543142
Pubmed	Developmental regulation of glycine receptors at efferent synapses of the murine cochlea.	GLRA3 GLRA1 GLRA2	4.96e-07	5	129	3	21850450
Pubmed	Native glycine receptor subtypes and their physiological roles.	GLRA3 GLRA1 GLRA2	4.96e-07	5	129	3	18721822
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	RPS6KA3 MINK1 NEK9 CXXC1 KLHL29 TSSK3 MERTK MAP4K2 MAP3K2 KLHL26	1.38e-06	372	129	10	22939624
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	VAPA MAPKAPK2 RPS6KA3 MINK1 AIP NEK9 MAP3K4 CEP170 NKTR EIF3G MERTK MAP3K7 PCDH18 MAP3K2 PPP6R3	1.54e-06	910	129	15	36736316
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH2 DNAH5 DNAH11	1.73e-06	7	129	3	9256245
Pubmed	Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.	GLRA3 GLRA1 GLRA2	1.73e-06	7	129	3	22988142
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH2 DNAH5 DNAH11	1.73e-06	7	129	3	31178125
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MINK1 AIP KIAA1671 ARHGAP1 TRMT10C P4HB PTPRZ1 AHNAK MPHOSPH9 HERC1 FTO MAP3K7 CNOT1 PRRC2B PPP6R3 PCNT	1.84e-06	1049	129	16	27880917
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	FLII FLNB FLNC POLA1 RPS6KA3 AIP CHORDC1 PLD3 NEK9 P4HB AHNAK CIAPIN1 EIF3G HERC1 FTO TATDN1 CNOT1 PPP6R3 HDGF	1.85e-06	1455	129	19	22863883
Pubmed	MEKK4 signaling regulates filamin expression and neuronal migration.	FLNB FLNC MAP3K4	2.75e-06	8	129	3	17145501
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNB MINK1 NEB AHNAK CEP250 HERC1 SNRNP70 DNAH5	2.82e-06	234	129	8	36243803
Pubmed	Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses.	GLRA3 GLRA1 GLRA2 SLC17A7	2.97e-06	27	129	4	19723784
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	MAGI3 AIP CHORDC1 KIAA1671 LENG8 ARHGAP1 CEP250 CIAPIN1 MPHOSPH9 EIF3G CNOT1 PRRC2B PPP6R3 PCNT	3.69e-06	853	129	14	28718761
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SFMBT1 CASP8AP2 FLNB NEK9 GREB1L KIAA1671 TXNIP AHNAK CNOT1 PCNT	3.90e-06	418	129	10	34709266
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	VAPA DOCK3 PITPNM2 FLII FLNB MINK1 NCAM1 PALMD CEP170 MAGI2 TRMT10C P4HB CADPS SNRNP70 MAP3K7 CNOT1	5.24e-06	1139	129	16	36417873
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	VAPA POLA1 SPCS2 CHORDC1 PLD3 CXXC1 KIAA1671 ARHGAP1 TRMT10C P4HB SCARB1 CIAPIN1 EIF3G PRRC2B HDGF	5.26e-06	1007	129	15	34597346
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	FLII FLNB SUPT20H ARID4A NEK9 CEP170 AHNAK MPHOSPH9 MAP3K7 CNOT1 HDGF PCNT	5.44e-06	645	129	12	25281560
Pubmed	Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.	VAPA FLNC NCAM1 MAGI2 JMJD7 P4HB PTPRZ1 FTO HDGF	5.50e-06	341	129	9	29791485
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNB FLNC POLA1 CEP170 P4HB AHNAK SMARCA2 SNRNP70 CNOT1 PRRC2B PPP6R3 PCNT	6.16e-06	653	129	12	22586326
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	VAPA DOCK3 MAGI3 KIAA1671 CEP170 ARHGAP1 TRMT10C P4HB AHNAK NKTR EIF3G SNRNP70 MAP3K7 PPP6R3	8.29e-06	916	129	14	32203420
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	FLII FLNB FLNC CEP170 P4HB AHNAK MAP4K2 MAP3K2 PCNT	8.50e-06	360	129	9	33111431
Pubmed	Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors.	GLRA1 GLRA2	1.37e-05	2	129	2	16144831
Pubmed	Characterization of the glycinergic input to bipolar cells of the mouse retina.	GLRA3 GLRA1	1.37e-05	2	129	2	16420443
Pubmed	Presence of ethanol-sensitive and ethanol-insensitive glycine receptors in the ventral tegmental area and prefrontal cortex in mice.	GLRA1 GLRA2	1.37e-05	2	129	2	34378188
Pubmed	Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site.	GLRA3 GLRA1	1.37e-05	2	129	2	23834509
Pubmed	Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels.	GLRA3 GLRA2	1.37e-05	2	129	2	27382060
Pubmed	Structure of the human alpha 2 subunit gene of the glycine receptor--use of vectorette and Alu-exon PCR.	GLRA1 GLRA2	1.37e-05	2	129	2	8973915
Pubmed	A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha.	FLNB FLNC	1.37e-05	2	129	2	9694715
Pubmed	Selective glycine receptor α2 subunit control of crossover inhibition between the on and off retinal pathways.	GLRA3 GLRA2	1.37e-05	2	129	2	22399754
Pubmed	Rare variants in dynein heavy chain genes in two individuals with situs inversus and developmental dyslexia: a case report.	DNAH5 DNAH11	1.37e-05	2	129	2	32357925
Pubmed	Discovery of type II inhibitors of TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2).	MAP3K7 MAP4K2	1.37e-05	2	129	2	25075558
Pubmed	Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.	GLRA3 GLRA1	1.37e-05	2	129	2	19959465
Pubmed	Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse.	GLRA3 GLRA1	1.37e-05	2	129	2	21486794
Pubmed	The limits of promiscuity: isoform-specific dimerization of filamins.	FLNB FLNC	1.37e-05	2	129	2	12525170
Pubmed	Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes.	GLRA1 GLRA2	1.37e-05	2	129	2	2155780
Pubmed	Effects of sleeve gastrectomy and rs9930506 FTO variants on angiopoietin/Tie-2 system in fat expansion and M1 macrophages recruitment in morbidly obese subjects.	TEK FTO	1.37e-05	2	129	2	27581034
Pubmed	Phylogenetic relationships and chromosomal location of five distinct glycine receptor subunit genes in the teleost Danio rerio.	GLRA1 GLRA2	1.37e-05	2	129	2	11685575
Pubmed	Multiple sites of ethanol action in alpha1 and alpha2 glycine receptors suggested by sensitivity to pressure antagonism.	GLRA1 GLRA2	1.37e-05	2	129	2	15147510
Pubmed	Phosphorylation of the Usher syndrome 1G protein SANS controls Magi2-mediated endocytosis.	MAGI2 USH1G	1.37e-05	2	129	2	24608321
Pubmed	Ciliary defects and genetics of primary ciliary dyskinesia.	DNAH5 DNAH11	1.37e-05	2	129	2	19410201
Pubmed	Glycine receptor α3 and α2 subunits mediate tonic and exogenous agonist-induced currents in forebrain.	GLRA3 GLRA2	1.37e-05	2	129	2	28784756
Pubmed	Activation of JNK signaling in osteoblasts is inversely correlated with collagen synthesis in age-related osteoporosis.	MAP3K4 MAP4K2	1.37e-05	2	129	2	30217450
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DOCK3 PITPNM2 FLII FLNC RTL6 RHBDF2 MAPKAPK2 CYTH3 C6orf132 AHNAK SCARB1 ZNF398 HERC1 PRRC2B PCNT	1.58e-05	1105	129	15	35748872
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH2 DNAH5 DNAH11	1.76e-05	14	129	3	9373155
Pubmed	MAP3Ks as central regulators of cell fate during development.	MAP3K4 MAP3K7 MAP3K2	2.20e-05	15	129	3	18855897
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PITPNM2 FLII FLNB FLNC MINK1 NCAM1 PLD3 PNMA8B CEP170 MAGI2 P4HB CADPS PTPRZ1 SLC17A7 CNOT1 PRRC2B DNAH11	2.30e-05	1431	129	17	37142655
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	VAPA FLNB FLNC SUPT20H POLA1 MAGI3 TRMT10C SMARCA2 HLTF MPHOSPH9 EIF3G CNOT1 PRRC2B PPP6R3	2.32e-05	1005	129	14	19615732
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	AKAP6 DOCK3 CASP8AP2 NEB DMXL1	2.47e-05	92	129	5	15840729
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	AKAP6 VAPA CASP8AP2 RHBDF2 EXPH5 SPCS2 GSDMB PLD3 NEB CEP170 GDAP1L1 AHNAK ZNF333 CX3CL1 PPP6R3 PCNT	2.50e-05	1293	129	16	15342556
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	FLII POLA1 CHORDC1 PLD3 NEK9 CEP170 P4HB SCARB1 CEP250 EIF3G PRRC2B PCNT	2.56e-05	754	129	12	33060197
Pubmed	Common genetic variants associated with cognitive performance identified using the proxy-phenotype method.	PITPNM2 CEP170 ASB18 TTLL11 MPHOSPH9	2.74e-05	94	129	5	25201988
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ATP13A4 DNAH2 MUC16 NEB NEK4 HOXB1 USH1G SMARCA2 CNOT1 PRRC2B DNAH11	2.74e-05	638	129	11	31182584
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PITPNM2 MAPKAPK2 APBA3 PALMD TRUB1 NEK9 CEP170 NEK4 ARHGAP1 MPHOSPH9 SNRNP70 MAP3K7 CNOT1 PPP6R3	3.30e-05	1038	129	14	26673895
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SUPT20H ARID4A POLA1 SPCS2 COX15 LIN52 LENG8 ARHGAP1 LINS1 P4HB PIK3CB FBXO42 NKTR CNOT1 PPP6R3 PCNT	3.41e-05	1327	129	16	32694731
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FLNB RTL6 ARHGAP1 AHNAK EIF3G DNAH5 CNOT1 PRRC2B	3.55e-05	332	129	8	37433992
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	KIAA1671 CEP250 NKTR MPHOSPH9 PCNT	3.87e-05	101	129	5	24613305
Pubmed	Loss of transforming growth factor-beta 2 leads to impairment of central synapse function.	GLRA1 GLRA2 SLC17A7	3.91e-05	18	129	3	18854036
Pubmed	Flt3- and Tie2-Cre tracing identifies regeneration in sepsis from multipotent progenitors but not hematopoietic stem cells.	RAG2 TEK	4.09e-05	3	129	2	36652946
Pubmed	Lymphocytes are not required for the rapid onset of coronary heart disease in scavenger receptor class B type I/apolipoprotein E double knockout mice.	RAG2 SCARB1	4.09e-05	3	129	2	15692099
Pubmed	Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.	FLNB FLNC	4.09e-05	3	129	2	12393796
Pubmed	The TGFβ-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1.	MAP3K4 MAP3K7	4.09e-05	3	129	2	23760366
Pubmed	Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit.	GLRA3 GLRA1	4.09e-05	3	129	2	17154252
Pubmed	Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.	FLNB FLNC	4.09e-05	3	129	2	11153914
Pubmed	Helicase-like transcription factor-deletion from the tumor microenvironment in a cell line-derived xenograft model of colorectal cancer reprogrammed the human transcriptome-S-nitroso-proteome to promote inflammation and redirect metastasis.	RAG2 HLTF	4.09e-05	3	129	2	34010296
Pubmed	Filamins as integrators of cell mechanics and signalling.	FLNB FLNC	4.09e-05	3	129	2	11252955
Pubmed	Hypothalamic FTO promotes high-fat diet-induced leptin resistance in mice through increasing CX3CL1 expression.	FTO CX3CL1	4.09e-05	3	129	2	37907171
Pubmed	Identification of MAGI-3 as a transforming growth factor-alpha tail binding protein.	MAGI3 MAGI2	4.09e-05	3	129	2	15652357
Pubmed	The CP110-interacting proteins Talpid3 and Cep290 play overlapping and distinct roles in cilia assembly.	CEP170 CEP250 PCNT	4.63e-05	19	129	3	24421332
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	VAPA FLII RPS6KA3 AIP TRUB1 PLD3 CEP170 LENG8 TRMT10C PAXBP1 P4HB AHNAK NKTR SNRNP70 CNOT1 PRRC2B	5.03e-05	1371	129	16	36244648
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	VAPA FLNB MINK1 MAGI3 C6orf132 KIAA1671 ARHGAP1 AHNAK SCARB1 CIAPIN1	5.17e-05	565	129	10	25468996
Pubmed	Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.	VAPA FLNB FLNC P4HB AHNAK EIF3G MAP3K7	5.41e-05	259	129	7	31162944
Pubmed	Genome-wide association analysis identifies 13 new risk loci for schizophrenia.	SFMBT1 PITPNM2 CEP170 NEK4 MPHOSPH9	5.57e-05	109	129	5	23974872
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EXPH5 C6orf132 KIAA1671 LENG8 P4HB CNOT1 PRRC2B	5.95e-05	263	129	7	34702444
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	DOCK3 GSDMB CCDC88B PNMA8B CEP170 LINS1 SNRNP70 PRRC2B	6.39e-05	361	129	8	26167880
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	VAPA FLNB MINK1 MAGI3 CEP170 ARHGAP1 AHNAK MPHOSPH9 EIF3G CNOT1 HDGF	6.98e-05	708	129	11	39231216
Pubmed	The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.	FLNB FLNC	8.15e-05	4	129	2	11739414
Pubmed	Structural interaction and functional regulation of polycystin-2 by filamin.	FLNB FLNC	8.15e-05	4	129	2	22802962
Pubmed	A potential role for the OTX2 homeoprotein in creating early 'highways' for axon extension in the rostral brain.	NCAM1 PTPRZ1	8.15e-05	4	129	2	9753681
Pubmed	Dynamic spatiotemporal expression patterns of neurocan and phosphacan indicate diverse roles in the developing and adult mouse olfactory system.	NCAM1 PTPRZ1	8.15e-05	4	129	2	10861539
Pubmed	Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers.	GLRA3 GLRA1	8.15e-05	4	129	2	28883437
Pubmed	Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia.	DNAH5 DNAH11	8.15e-05	4	129	2	18492703
Pubmed	The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.	RAG2 PIK3CB	8.15e-05	4	129	2	20699475
Pubmed	Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.	MAGI2 PTPRZ1	8.15e-05	4	129	2	17579610
Pubmed	Structural analysis of mouse glycine receptor alpha subunit genes. Identification and chromosomal localization of a novel variant.	GLRA1 GLRA2	8.15e-05	4	129	2	7507926
Pubmed	Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients.	NCAM1 SLC17A7	8.15e-05	4	129	2	23022470
Pubmed	Neuronal ER-plasma membrane junctions organized by Kv2-VAP pairing recruit Nir proteins and affect phosphoinositide homeostasis.	VAPA PITPNM2	8.15e-05	4	129	2	31594866
Pubmed	Survival kinase genes present prognostic significance in glioblastoma.	NEK9 PIK3CB	8.15e-05	4	129	2	26956052
Pubmed	Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb.	NCAM1 PTPRZ1	8.15e-05	4	129	2	19641104
Pubmed	Phosphoinositide 3-kinase β mediates microvascular endothelial repair of thrombotic microangiopathy.	RAG2 PIK3CB	8.15e-05	4	129	2	25139353
Pubmed	E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2.	MAP3K7 MAP3K2	8.15e-05	4	129	2	36161689
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	AKAP6 DOCK3 FLII FLNB SUPT20H CYTH3 MAGI3 AIP MAGI2 ARHGAP1 GDAP1L1 CADPS MERTK SNRNP70 PCNT	8.76e-05	1285	129	15	35914814
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	VAPA FLNB SPCS2 AIP PLD3 CEP170 ARHGAP1 TRMT10C P4HB AHNAK SCARB1 SNRNP70 CNOT1 PRRC2B PPP6R3	9.70e-05	1297	129	15	33545068
Interaction	MAP2K4 interactions	FLNB FLNC MAP3K4 ARHGAP1 MAP3K7 MAP4K2 MAP3K2	7.89e-07	81	127	7	int:MAP2K4
Interaction	PRNP interactions	VAPA FLNC SUPT20H NBEAL1 MAPKAPK2 POLA1 NCAM1 PLD3 CXXC1 MAGI2 JMJD7 P4HB PTPRZ1 SCARB1 NKTR EIF3G FTO PLEKHH2 PRRC2B HDGF DNAH11	1.11e-05	1158	127	21	int:PRNP
Cytoband	3p21.1	SFMBT1 ACY1 NEK4	2.30e-04	42	129	3	3p21.1
GeneFamily	Glycine receptors	GLRA3 GLRA1 GLRA2	8.93e-07	5	82	3	868
GeneFamily	Dyneins, axonemal	DNAH2 DNAH5 DNAH11	5.84e-05	17	82	3	536
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K4 MAP3K7 MAP3K2	1.70e-04	24	82	3	654
GeneFamily	Kelch like\|BTB domain containing	KLHL29 KLHL33 KLHL26	9.09e-04	42	82	3	617
GeneFamily	Mitogen-activated protein kinase-activated protein kinases	MAPKAPK2 RPS6KA3	1.09e-03	11	82	2	1156
GeneFamily	Protein disulfide isomerases	CASQ2 P4HB	4.03e-03	21	82	2	692
GeneFamily	PDZ domain containing	APBA3 MAGI3 MAGI2 AHNAK	5.05e-03	152	82	4	1220
GeneFamily	Fibronectin type III domain containing	NCAM1 TEK PTPRZ1 MERTK	6.05e-03	160	82	4	555
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	MAGI3 MAGI2	6.15e-03	26	82	2	904
Coexpression	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP	SUPT20H PLD3 NEB NEK9 ARHGAP1 AHNAK PCNT TBX2	5.42e-06	195	128	8	M3184
Coexpression	GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP	CASP8AP2 SUPT20H FA2H GLRA3 DMXL1 GLRA1 CEP250 DGKK	6.30e-06	199	128	8	M6218
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 FLNC NCAM1 CASQ2 PALMD GREB1L ASB18 CADPS ANKRD2	1.65e-10	184	129	10	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 FLNC NCAM1 CASQ2 PALMD GREB1L ASB18 CADPS ANKRD2	1.74e-10	185	129	10	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 FLNC NCAM1 CASQ2 PALMD GREB1L ASB18 ANKRD2	1.76e-09	170	129	9	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 FLNC NCAM1 CASQ2 PALMD GREB1L ASB18 ANKRD2	3.06e-09	181	129	9	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PITPNM2 AMPD3 CYTH3 NCAM1 SMARCA2 MERTK CX3CL1 TBX2	1.05e-07	195	129	8	7e0ef92059ff34e368d2324815f49b50e3ca7332
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CASQ2 GREB1L KLHL29 ASB18 LRRIQ1 PLEKHH2 DNAH11	8.01e-07	175	129	7	284fdc7a9d303636a637041846850d19d114861a
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNB TPGS2 PALMD TEK KIAA1671 TXNIP SMARCA2	8.32e-07	176	129	7	77516048aefbe1f48e825052756df0c310c1c486
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 FLNC NCAM1 CASQ2 ASB18 ANKRD2	8.32e-07	176	129	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNB TPGS2 PALMD TEK KIAA1671 TXNIP SMARCA2	8.32e-07	176	129	7	96779273b94345250cf53ba671203345b43d9e00
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 FLNC ABHD2 NCAM1 CASQ2 ANKRD2	1.04e-06	182	129	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 FLNC NCAM1 CASQ2 PALMD ASB18 CADPS	1.08e-06	183	129	7	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	AKAP6 FLNC NCAM1 PALMD GREB1L ASB18 ANKRD2	1.12e-06	184	129	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ABHD2 TEK TXNIP PTPRZ1 PLEKHH2 DNAH11	1.16e-06	185	129	7	efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ABHD2 TEK TXNIP PTPRZ1 PLEKHH2 DNAH11	1.16e-06	185	129	7	fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 FLNC NCAM1 CASQ2 PALMD ASB18 ANKRD2	1.39e-06	190	129	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	15-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	DNAH2 MUC16 C6orf132 KIAA1671 LRRIQ1 DNAH5 DNAH11	1.49e-06	192	129	7	9cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 ABHD2 NCAM1 CASQ2 GREB1L ASB18	1.54e-06	193	129	7	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AKAP6 DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11 IQCG	1.59e-06	194	129	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 NCAM1 CASQ2 GREB1L ASB18 CADPS	1.65e-06	195	129	7	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PITPNM2 AMPD3 CYTH3 NCAM1 MERTK CX3CL1 TBX2	1.65e-06	195	129	7	cad21edd90bf3e2fefdf5773a59cb1a664a69ddd
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 DOCK3 PITPNM2 FLNC CASQ2 TBX2 DNAH11	1.83e-06	198	129	7	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FLNB ARID4A NCAM1 TXNIP NKTR PLEKHH2 PCDH18	1.89e-06	199	129	7	615f20bf136dfef53b072667cf0e4df6a1017e05
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	FLNB FA2H ABHD2 GSDMB GNPNAT1 PIK3CB	7.04e-06	159	129	6	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 FLNC NCAM1 CASQ2 MERTK	1.03e-05	170	129	6	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 SUPT20H RPS6KA3 PAXBP1 AHNAK PCDH18	1.26e-05	176	129	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NCAM1 MAGI2 ANKRD2 PLEKHH2 PCDH18 TBX2	1.43e-05	180	129	6	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	LV\|World / Chamber and Cluster_Paper	AKAP6 NCAM1 PALMD TXNIP ASB18 ANKRD2	1.43e-05	180	129	6	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GREB1L KLHL29 MAGI2 ASB18 PLEKHH2 DNAH11	1.52e-05	182	129	6	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 TEK TXNIP PTPRZ1 PLEKHH2 DNAH11	1.52e-05	182	129	6	8a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 FA2H TEK TXNIP PTPRZ1 PLEKHH2	1.52e-05	182	129	6	3cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 FA2H TEK TXNIP PTPRZ1 PLEKHH2	1.52e-05	182	129	6	5d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 TEK TXNIP PTPRZ1 PLEKHH2 DNAH11	1.52e-05	182	129	6	e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC LRRIQ1 USH1G DNAH5 DNAH11 IQCG	1.62e-05	184	129	6	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC LRRIQ1 USH1G DNAH5 DNAH11 IQCG	1.62e-05	184	129	6	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC LRRIQ1 USH1G DNAH5 DNAH11 IQCG	1.62e-05	184	129	6	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	AKAP6 NCAM1 PALMD GREB1L ASB18 ANKRD2	1.67e-05	185	129	6	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 TNFSF18 KIAA1671 SCARB1 SMARCA2 CX3CL1	1.77e-05	187	129	6	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 FLNB PALMD TEK KIAA1671 CX3CL1	1.77e-05	187	129	6	dffa8447c2f3fdacf39a7258c6b4e81a25245041
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	AKAP6 ABHD2 CASQ2 NEB GREB1L CADPS	1.83e-05	188	129	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PITPNM2 CYTH3 COX15 MERTK CX3CL1 TBX2	1.88e-05	189	129	6	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNB PALMD TEK KIAA1671 TXNIP SMARCA2	1.88e-05	189	129	6	feedac2751ed770f80bc56fec31662b5b3826f58
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH2 MUC16 PALMD LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	7b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMPD3 NCAM1 SMARCA2 MERTK TBX2 DNAH11	2.00e-05	191	129	6	df8cdbc26443e55a203cbafa21b0952a2a55b9bf
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH2 MUC16 C6orf132 LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 ATP13A4 EXPH5 GREB1L LRRIQ1 DNAH5	2.00e-05	191	129	6	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH2 MUC16 PALMD LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCell	Control-Epithelial-Ciliated_cells\|Control / Condition, Lineage and Cell class	DNAH2 MUC16 PALMD LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	AKAP6 ABHD2 NCAM1 CASQ2 GREB1L CADPS	2.00e-05	191	129	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH2 MUC16 PALMD LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	b4e335e798c9617356b8e24412f9270c42dce656
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH2 MUC16 PALMD LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	c4b223b33c020a064f576711a3d700eb60a2d737
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH2 MUC16 C6orf132 LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	5129f778a9283bfac4ff322c21c5ca71da4b7174
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH2 MUC16 C6orf132 LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell	Control-Epithelial\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH2 MUC16 C6orf132 LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	b78547dae8328244a47c83346447bdd787efbcae
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH2 MUC16 C6orf132 LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	c50d6a1a6209ed4157f7c00fc24d4ecb43790f44
ToppCell	Control-Epithelial-Ciliated\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH2 MUC16 PALMD LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCell	Control-Epithelial\|Control / Condition, Lineage and Cell class	DNAH2 MUC16 PALMD LRRIQ1 DNAH5 DNAH11	2.00e-05	191	129	6	6228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCell	ASK452-Epithelial-Ciliated\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	PALMD LRRIQ1 FTO DNAH5 DNAH11 IQCG	2.12e-05	193	129	6	c0d10075862ac878aa05fc49c8b73e470783bf16
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AKAP6 EXPH5 DNAH2 PTPRZ1 DNAH5 DNAH11	2.12e-05	193	129	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 FLNB PALMD TEK KIAA1671 MERTK	2.12e-05	193	129	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAOA PALMD TEK KIAA1671 SCARB1 CX3CL1	2.12e-05	193	129	6	ff6e6b825d6c88148216c601580be3c28851ab5c
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	AKAP6 ABHD2 NCAM1 CASQ2 GREB1L CADPS	2.18e-05	194	129	6	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 ATP13A4 EXPH5 GREB1L LRRIQ1 DNAH5	2.18e-05	194	129	6	6b286992d4bb56013c0ea5a7601d3476d806175a
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	AKAP6 ABHD2 NCAM1 CASQ2 GREB1L CADPS	2.18e-05	194	129	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 ATP13A4 EXPH5 GREB1L LRRIQ1 DNAH5	2.18e-05	194	129	6	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 PALMD TEK KIAA1671 SCARB1 MAP4K2	2.18e-05	194	129	6	53a5e8863d79a052dff0758f389be5ac3883c721
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	AKAP6 DOCK3 NCAM1 CASQ2 GREB1L ASB18	2.24e-05	195	129	6	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	COVID-19-Epithelial-Ciliated_cells\|Epithelial / Condition, Lineage and Cell class	DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11 IQCG	2.31e-05	196	129	6	de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 PALMD TEK KIAA1671 SCARB1 MAP4K2	2.31e-05	196	129	6	2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 PALMD TEK KIAA1671 SCARB1 MAP4K2	2.31e-05	196	129	6	29ed8b1c4cd730db8632fde6eece404f1883a86d
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AKAP6 FLNC NCAM1 CASQ2 NEB ANKRD2	2.38e-05	197	129	6	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PITPNM2 PALMD TEK KIAA1671 SCARB1 MAP4K2	2.38e-05	197	129	6	a7922f65a8af4a773e4ce80114e4d895a594fa2f
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11 IQCG	2.38e-05	197	129	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11 IQCG	2.38e-05	197	129	6	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11 IQCG	2.38e-05	197	129	6	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11 IQCG	2.38e-05	197	129	6	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	EXPH5 DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11	2.38e-05	197	129	6	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKAP6 DOCK3 PITPNM2 FLNC CASQ2 DNAH11	2.44e-05	198	129	6	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 LRRIQ1 AHNAK DNAH5 DNAH11 IQCG	2.44e-05	198	129	6	d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	MAOA TXNIP SCARB1 CX3CL1 MAP4K2 TBX2	2.51e-05	199	129	6	80c8641cfd84436eadf2234f1313749e2f73331f
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 NEB TEK HOXB1 TATDN1	2.52e-05	119	129	5	c3f1223356e7f245a460ea5568a223e34e458dc1
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PITPNM2 FLNB PALMD TEK NKTR PCNT	2.59e-05	200	129	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	RHBDF2 AMACR NEB CCDC88B TSSK3 TBX2	2.59e-05	200	129	6	25f4c051c2e869481f33c22ad54de97efac444ad
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	RHBDF2 AMACR NEB CCDC88B TSSK3 TBX2	2.59e-05	200	129	6	da45a85a4667965b24ba824af871157af5b4cd19
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MORC1 EXPH5 GLRA3 USH1G	4.30e-05	67	129	4	52f6c244e8d89ccacb79bc5ef3663a5d01fd393c
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Adcyap1_(Dentate_hilum?)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MORC1 EXPH5 GLRA3 USH1G	4.30e-05	67	129	4	e462f9b5dca7c64101a31891f25654c05f2d215d
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 LRRIQ1 PTPRZ1 DNAH5 DNAH11	8.88e-05	155	129	5	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 LRRIQ1 PTPRZ1 DNAH5 DNAH11	8.88e-05	155	129	5	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	FA2H MUC16 LRRIQ1 MFSD8 DNAH11	9.15e-05	156	129	5	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EXPH5 GREB1L DGKK PLEKHH2 DNAH5	9.72e-05	158	129	5	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EXPH5 GREB1L DGKK PLEKHH2 DNAH5	9.72e-05	158	129	5	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP13A4 MAOA MAGI3 GREB1L DNAH5	1.09e-04	162	129	5	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 LRRIQ1 PTPRZ1 DNAH5 DNAH11	1.16e-04	164	129	5	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 ATP13A4 GREB1L LRRIQ1 DNAH5	1.19e-04	165	129	5	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DOCK3 ATP13A4 GREB1L LRRIQ1 DNAH5	1.19e-04	165	129	5	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MORC1 PNMA8B TXNIP PAXBP1 SNRNP70	1.23e-04	166	129	5	66026988509e39e41274fa0de738383219e8ff30
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Fos_(Layer_5,_medial_posterior_cortex_(Retrosplenial_cortex_(RSG),_subiculum))-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ASB18 HOXB1 TSSK3 KLHL33	1.25e-04	88	129	4	a909ea58f17716de9cf2486e648b89298b96e0d1
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Fos_(Layer_5,_medial_posterior_cortex_(Retrosplenial_cortex_(RSG),_subiculum))\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ASB18 HOXB1 TSSK3 KLHL33	1.25e-04	88	129	4	e38bee67177403cc06714b98e824a17055204586
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	MUC16 LRRIQ1 DNAH5 DNAH11 IQCG	1.26e-04	167	129	5	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH2 MUC16 LRRIQ1 DNAH5 DNAH11	1.33e-04	169	129	5	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLNB MUC16 PTPRZ1 DNAH5 CX3CL1	1.49e-04	173	129	5	464267a2ff3f5c387b6c9c6fa4dab135a221f448
Computational	AcetylCholine receptors.	GLRA3 GLRA1 GLRA2	1.52e-04	14	83	3	MODULE_328
Computational	Neurotransmitter (GABA) receptor.	GLRA3 GLRA1 GLRA2	1.89e-04	15	83	3	MODULE_215
Computational	Genes in the cancer module 267.	GLRA3 GLRA1 GLRA2	1.89e-04	15	83	3	MODULE_267
Drug	protostrychnine	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID005320746
Drug	7-nitroindoline	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID013566747
Drug	SC-49648	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID000195696
Drug	akuammiline	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID005367018
Drug	N-methyl-THIP	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID000134373
Drug	SC-48981	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID000126573
Drug	iso-THAZ	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID003047783
Drug	2-(phosphonomethyl)phenylalanine	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID000383689
Drug	NSC381080	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID000165497
Drug	SC-50132	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID000195719
Drug	SR 42641	GLRA3 GLRA1 GLRA2	6.91e-07	4	128	3	CID000129049
Drug	milacemide	MAOA GLRA3 GLRA1 GLRA2	1.24e-06	15	128	4	CID000053568
Drug	Lindane	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	DB00431
Drug	pleiocarpamine	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID000558637
Drug	azetidine-3-carboxylic acid	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID000093192
Drug	Cao C	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID000166617
Drug	oxanilide	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID000069288
Drug	iso-THAO	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID000127199
Drug	ALX1393	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID016078939
Drug	mafoprazine	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID000071241
Drug	gevotroline	GLRA3 GLRA1 GLRA2	1.72e-06	5	128	3	CID000060546
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A	AMPD3 MAOA MAPKAPK2 MINK1 PLD3 NEK9 GLRA1 CEP250 MERTK	1.78e-06	197	128	9	2253_DN
Drug	THAZ	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000171289
Drug	thiomuscimol	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000005448
Drug	thio-THIP	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000656720
Drug	AC1L90PQ	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000436036
Drug	mV GABA	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000128435
Drug	caged glycine	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000192642
Drug	brometone	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000006424
Drug	minaxolone	GLRA3 GLRA1 GLRA2	3.43e-06	6	128	3	CID000071960
Drug	propanethiol	DOCK3 GLRA3 GLRA1 GLRA2	4.31e-06	20	128	4	CID000007848
Drug	R 5135	MAOA GLRA3 GLRA1 GLRA2	5.30e-06	21	128	4	CID000119544
Drug	L-serinamide	GLRA3 GLRA1 GLRA2	5.98e-06	7	128	3	CID000101138
Drug	Boc-glycine	GLRA3 GLRA1 GLRA2	5.98e-06	7	128	3	CID000078288
Drug	alpha-EMTBL	GLRA3 GLRA1 GLRA2	5.98e-06	7	128	3	CID000128423
Drug	CID189778	GLRA3 GLRA1 GLRA2	5.98e-06	7	128	3	CID000189778
Drug	propyl methanethiosulfonate	GLRA3 GLRA1 GLRA2	5.98e-06	7	128	3	CID000529387
Drug	thiocolchicoside	GLRA3 GLRA1 GLRA2	5.98e-06	7	128	3	CID000072067
Drug	PK 8165	GLRA3 GLRA1 GLRA2	5.98e-06	7	128	3	CID000071219
Drug	WT702	GLRA3 GLRA1 GLRA2	9.52e-06	8	128	3	CID000089643
Drug	isostrychnine	GLRA3 GLRA1 GLRA2	9.52e-06	8	128	3	CID000264626
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A	NCAM1 GREB1L MAGI2 ARHGAP1 AHNAK SCARB1 MERTK TBX2	1.38e-05	193	128	8	6678_UP
Drug	NSC129536	GLRA3 GLRA1 GLRA2	1.42e-05	9	128	3	CID000004815
Drug	Atonik	GLRA3 GLRA1 GLRA2	1.42e-05	9	128	3	CID000069471
Drug	nortropanol	GLRA3 GLRA1 GLRA2	1.42e-05	9	128	3	CID000068147
Drug	AC1NSJX8	GLRA3 GLRA1 GLRA2	1.42e-05	9	128	3	CID005311059
Drug	SR 57227A	GLRA3 GLRA1 GLRA2	1.42e-05	9	128	3	CID000131746
Drug	DCQX	GLRA3 GLRA1 GLRA2	1.42e-05	9	128	3	CID000001845
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	MAPKAPK2 ABHD2 PLD3 CXXC1 ARHGAP1 CEP250 SMARCA2 SNRNP70	1.55e-05	196	128	8	4956_DN
Drug	Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A	GLRA3 NCAM1 NEK9 GREB1L KLHL29 GLRA1 FBXO42 GPRIN2	1.55e-05	196	128	8	5622_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	SUPT20H TXNIP ARHGAP1 LINS1 SCARB1 CEP250 FBXO42 PRRC2B	1.55e-05	196	128	8	1628_DN
Drug	nickel hydroxide	SUPT20H TNFSF18 MAPKAPK2 MINK1 MAP3K4 MAP3K7 CX3CL1 MAP4K2 MAP3K2	1.63e-05	259	128	9	CID000025500
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A	MORC1 DOCK3 MAOA MAPKAPK2 AMACR CEP250 SLC17A7 NKTR	1.67e-05	198	128	8	5278_UP
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A	MAOA APBA3 NEB LINS1 NKTR MAP4K2 PRRC2B TBX2	1.67e-05	198	128	8	6314_DN
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ARID4A MAPKAPK2 ABHD2 PLD3 ARHGAP1 PIK3CB SMARCA2 MAP3K2	1.73e-05	199	128	8	1705_UP
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; HL60; HT_HG-U133A	MAOA EXPH5 MINK1 ARHGAP1 SCARB1 SLC17A7 NKTR MAP3K2	1.73e-05	199	128	8	1277_UP
Drug	THBA	GLRA3 GLRA1 GLRA2	2.02e-05	10	128	3	CID000130993
Drug	Blue Shield	GLRA3 GLRA1 GLRA2 TBX2	2.33e-05	30	128	4	CID000014830
Drug	ip 0	GLRA3 GLRA1 GLRA2	2.77e-05	11	128	3	CID000006943
Drug	colchicoside	GLRA3 GLRA1 GLRA2	3.68e-05	12	128	3	CID000092763
Drug	harmaline	MAOA GLRA3 GLRA1 GLRA2	3.88e-05	34	128	4	CID000022381
Drug	tridecane	CASQ2 CXXC1 GLRA1 GLRA2 SMARCA2 SLC17A7	5.80e-05	119	128	6	CID000012388
Drug	ABPH	GLRA3 GLRA1 GLRA2	6.04e-05	14	128	3	CID000092377
Drug	quinoxaline-2,3-dione	GLRA3 GLRA1 GLRA2	6.04e-05	14	128	3	CID011469229
Drug	ACEA-1011	GLRA3 GLRA1 GLRA2	7.52e-05	15	128	3	CID000127872
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	MAPKAPK2 ABHD2 APBA3 NEK9 TXNIP AHNAK SMARCA2	8.06e-05	183	128	7	1668_UP
Drug	5 beta-alphaxalone	FLII GLRA3 GLRA1 GLRA2	9.04e-05	42	128	4	CID000068930
Drug	LY233536	GLRA3 GLRA1 GLRA2	9.21e-05	16	128	3	CID000126239
Drug	cyanotriphenylborate	GLRA1 GLRA2	9.37e-05	3	128	2	CID000151925
Drug	7-chloro-4-quinolinol	GLRA1 GLRA2	9.37e-05	3	128	2	CID000066593
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	FLNB POLA1 PLD3 NEK9 AHNAK HERC1 MAP3K2	1.05e-04	191	128	7	4168_DN
Drug	ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A	FLII MAPKAPK2 MINK1 GLRA3 GREB1L SCARB1 MAP3K7	1.05e-04	191	128	7	5964_DN
Drug	7-Cl-Thio-Kyna	GLRA3 GLRA1 GLRA2	1.11e-04	17	128	3	CID003035668
Drug	zatosetron	GLRA3 GLRA1 GLRA2	1.11e-04	17	128	3	CID000060763
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A	SUPT20H TNFSF18 CYTH3 MINK1 NEK9 GREB1L GPRIN2	1.12e-04	193	128	7	3814_DN
Drug	Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A	AMPD3 MAOA MINK1 PLD3 CEP250 PRRC2B KLHL26	1.16e-04	194	128	7	6467_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A	FLII MAOA ABHD2 PALMD PLD3 MAP3K7 IQCG	1.24e-04	196	128	7	4645_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HG-U133A	SUPT20H NEK9 PAXBP1 MPHOSPH9 CNOT1 PRRC2B KLHL26	1.28e-04	197	128	7	1938_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	RHBDF2 GSDMB PLD3 NEB ARHGAP1 LINS1 MAP3K2	1.28e-04	197	128	7	3456_DN
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A	SUPT20H MAOA POLA1 APBA3 TXNIP PIK3CB MPHOSPH9	1.32e-04	198	128	7	6287_DN
Drug	Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; HL60; HG-U133A	AKAP6 ABHD2 MINK1 NCAM1 MPHOSPH9 MERTK GPRIN2	1.32e-04	198	128	7	1748_UP
Drug	Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; HL60; HT_HG-U133A	RHBDF2 AMACR MINK1 NCAM1 AHNAK SLC17A7 MERTK	1.32e-04	198	128	7	6142_UP
Drug	estradiol, USP; Up 200; 0.01uM; HL60; HG-U133A	FLNB NEK9 TXNIP AHNAK SMARCA2 MPHOSPH9 MAP3K7	1.32e-04	198	128	7	782_UP
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; PC3; HT_HG-U133A	MORC1 RAG2 ABHD2 ARHGAP1 LINS1 SCARB1 SLC17A7	1.32e-04	198	128	7	6351_UP
Drug	MNQX	GLRA3 GLRA1 GLRA2	1.33e-04	18	128	3	CID000130818
Drug	Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	APBA3 NEK4 ARHGAP1 LINS1 SMARCA2 PRRC2B KLHL26	1.36e-04	199	128	7	2618_DN
Drug	Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	MORC1 FLNB MAPKAPK2 ABHD2 MINK1 KLHL29 NKTR	1.36e-04	199	128	7	6489_UP
Drug	Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A	SUPT20H RHBDF2 EXPH5 APBA3 CXXC1 MAP3K7 PRRC2B	1.40e-04	200	128	7	1953_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A	SUPT20H APBA3 GREB1L AHNAK GLRA1 SLC17A7 TBX2	1.40e-04	200	128	7	5762_UP
Drug	AC1L1CMQ	GLRA3 GLRA1 GLRA2	1.57e-04	19	128	3	CID000001968
Drug	PNU-120596	GLRA3 GLRA1 GLRA2	1.57e-04	19	128	3	CID000311434
Drug	5,7-dichlorokynurenic acid	GLRA3 GLRA1 GLRA2 SLC17A7	1.66e-04	49	128	4	CID000001779
Drug	di-Z	GLRA3 GLRA1 GLRA2	1.84e-04	20	128	3	CID000656933
Drug	Picrotoxin	GLRA3 GLRA2	1.87e-04	4	128	2	DB00466
Drug	ethyltrimethylammonium	GLRA3 GLRA1 GLRA2	2.14e-04	21	128	3	CID000033993
Drug	meproadifen	GLRA3 GLRA1 GLRA2	2.14e-04	21	128	3	CID000189752
Drug	Z-Gly	GLRA3 GLRA1 GLRA2	2.47e-04	22	128	3	CID000014349
Drug	N-chlorosuccinimide	GLRA3 GLRA1 GLRA2 ZNF398	2.79e-04	56	128	4	CID000031398
Drug	cyclothiazide	GLRA3 PTPRZ1 GLRA1 GLRA2 SLC17A7	2.93e-04	103	128	5	CID000002910
Drug	nipecotic acid	GLRA3 GLRA1 GLRA2 SLC17A7	2.99e-04	57	128	4	CID000004498
Disease	alcohol consumption measurement	AKAP6 TMEM229A ARID4A DNAH2 GLRA3 MAGI3 NCAM1 KLHL29 MAGI2 CADPS FBXO42 FTO SNRNP70 MAP3K7 DNAH5 PPP6R3 HDGF	1.80e-05	1242	124	17	EFO_0007878
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNB FLNC	5.24e-05	3	124	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNB FLNC	5.24e-05	3	124	2	DOID:0111190 (implicated_via_orthology)
Disease	alopecia areata	TNFSF18 MAGI3 CCDC88B PLEKHH2	5.89e-05	50	124	4	EFO_0004192
Disease	Kartagener syndrome (is_implicated_in)	DNAH5 DNAH11	1.05e-04	4	124	2	DOID:0050144 (is_implicated_in)
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	AKAP6 MORC1 FLII ARID4A MINK1 NCAM1 CCDC88B KLHL29 MAGI2 HERC1 MAP3K7 PRRC2B	1.46e-04	801	124	12	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ACY1 TEK AHNAK SCARB1 MERTK	4.14e-04	148	124	5	C0279702
Disease	leukopenia, response to thiopurine	CADPS FTO	4.82e-04	8	124	2	EFO_0004233, EFO_0006317
Disease	interleukin 1 receptor antagonist measurement	AKAP6 EXPH5 DNAH11	1.46e-03	53	124	3	EFO_0004754
Disease	Kartagener syndrome (implicated_via_orthology)	DNAH5 DNAH11	1.54e-03	14	124	2	DOID:0050144 (implicated_via_orthology)
Disease	cortical surface area measurement	PITPNM2 FLNB NBEAL1 NCAM1 KLHL29 ARHGAP1 HOXB1 LRRIQ1 CADPS GLRA1 FBXO42 MPHOSPH9 MAP3K7 DNAH11	1.58e-03	1345	124	14	EFO_0010736
Disease	thyroid volume	SMARCA2 DNAH5	2.02e-03	16	124	2	EFO_0004865
Disease	bacteriemia	DOCK3 MAGI3	2.29e-03	17	124	2	EFO_0003033
Disease	cutaneous melanoma, hair color	AMPD3 AHNAK FTO	2.29e-03	62	124	3	EFO_0000389, EFO_0003924
Disease	Cannabis use initiation	KLHL29 ZNF766	2.56e-03	18	124	2	EFO_0007586
Disease	lifestyle measurement	DOCK3 CHORDC1 CADPS TTLL11 SMARCA2	3.21e-03	235	124	5	EFO_0010724
Disease	tissue plasminogen activator measurement, coronary artery disease	NBEAL1 MAP3K4 SCARB1	3.36e-03	71	124	3	EFO_0001645, EFO_0004791
Disease	bone density, lean body mass	FTO PPP6R3	3.49e-03	21	124	2	EFO_0003923, EFO_0004995
Disease	hemorrhoid	SFMBT1 AMPD3 NCAM1 MERTK	3.49e-03	147	124	4	EFO_0009552
Disease	Bronchiectasis	DNAH5 DNAH11	3.83e-03	22	124	2	C0006267
Disease	Alzheimer disease, educational attainment	DOCK3 PITPNM2 CEP170 TTLL11 SMARCA2	3.96e-03	247	124	5	EFO_0011015, MONDO_0004975
Disease	Bipolar Disorder	VAPA MAOA NCAM1 NEK4 MAGI2 SLC17A7 PCNT	4.11e-03	477	124	7	C0005586
Disease	Schizophrenia	MAOA AMACR NCAM1 MAGI2 ARHGAP1 PIK3CB PTPRZ1 SMARCA2 SLC17A7 PCNT	4.16e-03	883	124	10	C0036341
Disease	Ovarian Serous Adenocarcinoma	TEK MAP3K4	4.18e-03	23	124	2	C1335177

Protein segments in the cluster

Peptide	Gene	Start	Entry
NAPDEDGMTPTLWAA	USH1G	26	Q495M9
FAPPNTSDMEAVWKE	VAPA	101	Q9P0L0
NPPQMLWERTEEDSK	CEP170	341	Q5SW79
MPTGDFDSKPSWADQ	EIF3G	1	O75821
PDNWKMDISEILESS	ARID4A	261	P29374
PLQAAAMDPQASDWS	CCDC88B	561	A6NC98
PKMDSSVPWKTQSEA	ATP13A4	326	Q4VNC1
EGSVLFPEPLTWMDK	ABHD2	381	P08910
KSDELPNQMSMDDWP	AMACR	251	Q9UHK6
MEQNWDELASSPPDM	GSDMB	371	Q8TAX9
VPSEDLTPDSQWDPM	APBA3	26	O96018
DPAAAKLWTLSANDM	CIAPIN1	191	Q6FI81
LLPWADKIAQFTMDP	DNAH11	2461	Q96DT5
VNAPDVQAPDWHLKM	AHNAK	2496	Q09666
VASPCPKMISDDNWS	CASP8AP2	1366	Q9UKL3
PKMISDDNWSLLSSE	CASP8AP2	1371	Q9UKL3
PAMQKDDPTWSELRA	DMXL1	1591	Q9Y485
DPWAMTDEEKAKAVP	AIP	166	O00170
MFSDKSPNPDVWTSE	AMPD3	536	Q01432
LEDSNLPPKVWHSEM	IQCG	6	Q9H095
LSPWKCQESDMADLP	NBEAL1	811	Q6ZS30
EMETPDWTPDIKHSK	RAG2	301	P55895
LDLDPSMLDSIWKPD	GLRA3	116	O75311
DVSLPQSEHKEPWFM	GDAP1L1	76	Q96MZ0
LWKSPMEDDNERPTG	MFSD8	386	Q8NHS3
PSSKWLPAMEEIPEN	PCDH18	1081	Q9HCL0
LPTAWATMKQREDPE	MAP4K2	441	Q12851
PSWKSLLNVPMEDVN	MORC1	771	Q86VD1
IDNMGKEIPTDAPWE	MAOA	131	P21397
VDMDAALEVQPPDTW	CADPS	931	Q9ULU8
DLNWDLKPASSSNPM	FBXO42	501	Q6P3S6
EKEKSTPSAPWITEM	MUC16	3871	Q8WXI7
WEESNVMQDKDAPSP	PALMD	351	Q9NP74
EPANELPMNEIEAWK	PLD3	16	Q8IV08
WMNPIFVPEEKSSDT	DGKK	1196	Q5KSL6
EPSQEDWEEMAPLSQ	KLHL33	296	A6NCF5
PPMSLAEAEQLMEEW	FLII	886	Q13045
TSSPPKWMAEIERDD	LIN52	51	Q52LA3
SWASDAPSEPLKAVM	LINS1	591	Q8NG48
PDPLPDNWEMAYTEK	MAGI2	301	Q86UL8
TLEPLPKNWEMAYTD	MAGI3	291	Q5TCQ9
FPNPEWSEVSEEVKM	MAPKAPK2	286	P49137
MDKDERSDEPSPQWL	KIAA1671	1776	Q9BY89
MDPKPDLDSDSWCLL	NEK9	956	Q8TD19
ESSDNVDIRWMKPPT	MERTK	396	Q12866
PWASEALGKMPDAVN	JMJD7	151	P0C870
WEKDDASMPLPFDLT	FTO	476	Q9C0B1
LADPWQKMAVESPSD	RPS6KA3	6	P51812
NDDWMKDPSAQLPTG	ASB18	51	Q6ZVZ8
TPMHENPEWEKARQA	LENG8	31	Q96PV6
NLSGKPDDWPQDMKE	LENG8	281	Q96PV6
PVSPEEQDTAYWMKT	HERC1	1161	Q15751
MGQKENLWASDSPDP	C9orf131	501	Q5VYM1
MPVTEKDLAEDAPWK	FLNB	1	O75369
KSSAQPENLIPMWSS	NEK4	416	P51957
PMWSSDIVTGEKNEP	NEK4	426	P51957
MPSTEKDLAEDAPWK	FLNC	21	Q14315
WPARIDEMPEAAVKS	HDGF	26	P51858
CWSKDPSQRPSMEEI	MAP3K7	266	O43318
TEKPPWAEFEAMAAI	MAP3K2	556	Q9Y2U5
KPDETPNAWMSDSGT	MPHOSPH9	196	Q99550
EMAEEEDPSWPSTAM	LCT	1231	P09848
EDEMQKSAWDQPSLP	EXPH5	1556	Q8NEV8
IKPHLMSQELPEDWD	P4HB	351	P07237
MSQELPEDWDKQPVK	P4HB	356	P07237
ESLKDPSMEGNVWFP	PTPRZ1	641	P23471
PKLTVIAENMWDPFS	PAXBP1	686	Q9Y5B6
WSSNDLMDKIESPEP	PITPNM2	366	Q9BZ72
EPWPDIESFSKMPFD	GREB1L	1371	Q9C091
DVIKNWDSLIPDEMP	PCNT	2161	O95613
EPMAAKAWDKESEPA	POLA1	266	P09884
MAELSEPEGPVDWKE	PLEKHH2	1	Q8IVE3
PDIPEKWMDSVSSHS	LRRIQ1	1261	Q96JM4
TDPAMEPRFKVVDWD	FA2H	106	Q7L5A8
MWQPKDSVLDPNVAH	CCDC105	46	Q8IYK2
SAPVDWRDPSQMEKL	C6orf132	456	Q5T0Z8
KAPEALWPAEAVMDG	ANKRD2	16	Q9GZV1
WMSDTEESPFLDPAL	CXXC1	306	Q9P0U4
EPNTPTARTFDWMKV	HOXB1	171	P14653
DQWEFKAPMSEPRVL	KLHL26	486	Q53HC5
SMPSQAWNADEDLEP	DOCK3	1916	Q8IZD9
AEPSPDGMEKQSWRQ	CEP250	2256	Q9BV73
PAPAWLSMEMEALQE	C1orf112	826	Q9NSG2
ISAPSPEEKEEWMKS	CYTH3	361	O43739
SLDLDPSMLDSIWKP	GLRA2	116	P23416
TPMFDPSLLKEVDWS	GNPNAT1	6	Q96EK6
SVWMEIPDDDDLPTA	CASQ2	341	O14958
KPMSWHDNLEEPADA	FAM183BP	51	Q6ZVS7
MVSRENSKELPPFWE	HLTF	251	Q14527
KEMKPPTSQEEWEAE	COX15	106	Q7KZN9
NSFPKMGESWIPEDL	COX15	291	Q7KZN9
KDVWTMTSANDLAPA	GPRIN2	311	O60269
TNAAPEKAMLPGEWE	DNAH2	3766	Q9P225
EVTKWMKDDISAPPT	DNAH5	4516	Q8TE73
MNPADKPAWAREVEE	MINK1	511	Q8N4C8
WEELKAMDLPSFEPA	MAP3K4	601	Q9Y6R4
GEAEKWAIPHMQPDS	RTL6	146	Q6ICC9
EVETELKMWDPHNDP	SNRNP70	81	P08621
PDSWSLEMDLKPDAI	RGSL1	261	A5PLK6
SIPSEKLMIETDAPW	TATDN1	211	Q6P1N9
APKASQLDAWLEMNP	SMARCA2	611	P51531
TAEAPAESATLPAWM	TMEM229A	41	B2RXF0
DDSSETPPHWKEEMQ	NKTR	356	P30414
KPMSWHDNLEEPADA	FAM183A	51	A6NL82
LDLDPSMLDSIWKPD	GLRA1	111	P23415
PSDPWAREEMLKIAS	PNMA8B	341	Q9ULN7
ASIDEKNWPSDEMPD	ARHGAP1	26	Q07960
KNWPSDEMPDFPKSD	ARHGAP1	31	Q07960
IDPSSLSFNMWKEIP	SCARB1	46	Q8WTV0
SGEKQPWAEPEEMSE	SLC17A7	491	Q9P2U7
SWSSFPDELEEMLNP	PIK3CB	461	P42338
SEIADPEMPLAWKEI	B3GALT9	311	A8MXE2
NEAMETTENWTPPKA	AKAP6	796	Q13023
TTENWTPPKAEMDDL	AKAP6	801	Q13023
AQKWMHPQVTPTDDS	ACY1	306	Q03154
KAEPMQWASLELPAA	CHORDC1	306	Q9UHD1
QSKMKPSDLSQVWPE	CNOT1	821	A5YKK6
PEPTMSWTKDGEQIE	NCAM1	241	P13591
QVQMVKDDDPSWKPT	TTLL11	321	Q8NHH1
DSPATGEQWMAKPVA	TBX2	191	Q13207
ASLPFDDTDIPKMLW	TSSK3	206	Q96PN8
KDPTGMDPDDIWQLS	SPCS2	146	Q15005
MASSEPPCVNKVSDW	TNFSF18	71	Q9UNG2
MAEAAPAPTSEWDSE	ZNF398	1	Q8TD17
DMWKRSPCNLAIPSE	SUPT20H	291	Q8NEM7
MESARKAWENSPSLP	PRRC2B	1856	Q5JSZ5
KASGWPLPTNEEMTL	TEK	371	Q02763
WESQLKPEELPSMQD	ZNF333	76	Q96JL9
EKPPAERHMISSWEQ	TPGS2	41	Q68CL5
EKLLAEAGMPSPEWT	TRUB1	91	Q8WWH5
SVNMKLEAVDPWSPF	SFMBT1	276	Q9UHJ3
EPWTVENEMKVAKNP	ZNF766	66	Q5HY98
EMSWVDLNIPDTPEA	TXNIP	316	Q9H3M7
ATFVKWQDDTGPPMD	RHBDF2	521	Q6PJF5
DKMEVDLSEPPNWSA	PPP6R3	671	Q5H9R7
PPSEELELDKWKTTM	TRMT10C	56	Q7L0Y3
MDPSADTWDLSSPLI	TYW1B	1	Q6NUM6
SWTPKAEEPIHATMD	CX3CL1	306	P78423
SYPVSADKMWPENEK	ZNF311	136	Q5JNZ3
WDTDEPPSKQMRESD	KLHL29	126	Q96CT2
WDNDKKTIHVMPDTP	NEB	3456	P20929